vs
美国铁塔(AMT)与福泰制药(VRTX)财务数据对比。点击上方公司名可切换其他公司
福泰制药的季度营收约是美国铁塔的1.2倍($3.2B vs $2.7B),美国铁塔净利率更高(110.1% vs 37.3%,领先72.8%),福泰制药同比增速更快(9.5% vs 6.8%),美国铁塔自由现金流更多($941.0M vs $348.6M),过去两年福泰制药的营收复合增速更高(8.9% vs 3.7%)
美国铁塔是全球规模最大的房地产投资信托基金(REIT)之一,作为领先的独立多租户通信地产持有、运营及开发商,目前在全球范围内拥有约21.9万个通信站点,为全球通信产业提供可靠的基础设施支持。
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业,是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外,公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
AMT vs VRTX — 直观对比
营收规模更大
VRTX
是对方的1.2倍
$2.7B
营收增速更快
VRTX
高出2.7%
6.8%
净利率更高
AMT
高出72.8%
37.3%
自由现金流更多
AMT
多$592.4M
$348.6M
两年增速更快
VRTX
近两年复合增速
3.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.7B | $3.2B |
| 净利润 | $3.0B | $1.2B |
| 毛利率 | — | 85.4% |
| 营业利润率 | 0.0% | 37.8% |
| 净利率 | 110.1% | 37.3% |
| 营收同比 | 6.8% | 9.5% |
| 净利润同比 | -2.6% | 30.5% |
| 每股收益(稀释后) | — | $4.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMT
VRTX
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $3.2B | ||
| Q3 25 | $2.7B | $3.1B | ||
| Q2 25 | $2.6B | $3.0B | ||
| Q1 25 | $2.6B | $2.8B | ||
| Q4 24 | $2.5B | $2.9B | ||
| Q3 24 | $2.5B | $2.8B | ||
| Q2 24 | $2.5B | $2.6B |
净利润
AMT
VRTX
| Q1 26 | $3.0B | — | ||
| Q4 25 | $836.8M | $1.2B | ||
| Q3 25 | $912.6M | $1.1B | ||
| Q2 25 | $380.5M | $1.0B | ||
| Q1 25 | $498.6M | $646.3M | ||
| Q4 24 | $1.2B | $913.0M | ||
| Q3 24 | $-780.4M | $1.0B | ||
| Q2 24 | $908.4M | $-3.6B |
毛利率
AMT
VRTX
| Q1 26 | — | — | ||
| Q4 25 | — | 85.4% | ||
| Q3 25 | — | 86.5% | ||
| Q2 25 | — | 86.3% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 85.5% | ||
| Q3 24 | — | 85.8% | ||
| Q2 24 | — | 85.9% |
营业利润率
AMT
VRTX
| Q1 26 | 0.0% | — | ||
| Q4 25 | 42.4% | 37.8% | ||
| Q3 25 | 45.4% | 38.6% | ||
| Q2 25 | 45.6% | 38.8% | ||
| Q1 25 | 48.9% | 22.7% | ||
| Q4 24 | 42.4% | 35.2% | ||
| Q3 24 | 45.2% | 40.3% | ||
| Q2 24 | 45.4% | -132.9% |
净利率
AMT
VRTX
| Q1 26 | 110.1% | — | ||
| Q4 25 | 30.6% | 37.3% | ||
| Q3 25 | 33.6% | 35.2% | ||
| Q2 25 | 14.5% | 34.8% | ||
| Q1 25 | 19.5% | 23.3% | ||
| Q4 24 | 48.3% | 31.4% | ||
| Q3 24 | -30.9% | 37.7% | ||
| Q2 24 | 35.7% | -135.8% |
每股收益(稀释后)
AMT
VRTX
| Q1 26 | — | — | ||
| Q4 25 | $1.76 | $4.64 | ||
| Q3 25 | $1.82 | $4.20 | ||
| Q2 25 | $0.78 | $3.99 | ||
| Q1 25 | $1.04 | $2.49 | ||
| Q4 24 | $2.63 | $3.62 | ||
| Q3 24 | $-1.69 | $4.01 | ||
| Q2 24 | $1.92 | $-13.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $6.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.2B | $18.7B |
| 总资产 | — | $25.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AMT
VRTX
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.5B | $6.6B | ||
| Q3 25 | $2.0B | $6.3B | ||
| Q2 25 | $2.1B | $6.4B | ||
| Q1 25 | $2.1B | $6.2B | ||
| Q4 24 | $2.0B | $6.1B | ||
| Q3 24 | $2.2B | $6.5B | ||
| Q2 24 | $2.2B | $5.8B |
总债务
AMT
VRTX
| Q1 26 | — | — | ||
| Q4 25 | $33.8B | — | ||
| Q3 25 | $34.9B | — | ||
| Q2 25 | $35.2B | — | ||
| Q1 25 | $34.0B | — | ||
| Q4 24 | $32.8B | — | ||
| Q3 24 | $33.4B | — | ||
| Q2 24 | $35.6B | — |
股东权益
AMT
VRTX
| Q1 26 | $10.2B | — | ||
| Q4 25 | $3.7B | $18.7B | ||
| Q3 25 | $4.0B | $17.3B | ||
| Q2 25 | $3.7B | $17.2B | ||
| Q1 25 | $3.5B | $16.5B | ||
| Q4 24 | $3.4B | $16.4B | ||
| Q3 24 | $3.6B | $15.6B | ||
| Q2 24 | $3.9B | $14.8B |
总资产
AMT
VRTX
| Q1 26 | — | — | ||
| Q4 25 | $63.2B | $25.6B | ||
| Q3 25 | $63.9B | $24.9B | ||
| Q2 25 | $63.8B | $24.0B | ||
| Q1 25 | $62.1B | $22.9B | ||
| Q4 24 | $61.1B | $22.5B | ||
| Q3 24 | $62.8B | $22.2B | ||
| Q2 24 | $65.8B | $20.1B |
负债/权益比
AMT
VRTX
| Q1 26 | — | — | ||
| Q4 25 | 9.26× | — | ||
| Q3 25 | 8.82× | — | ||
| Q2 25 | 9.48× | — | ||
| Q1 25 | 9.63× | — | ||
| Q4 24 | 9.70× | — | ||
| Q3 24 | 9.16× | — | ||
| Q2 24 | 9.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $498.0M |
| 自由现金流经营现金流 - 资本支出 | $941.0M | $348.6M |
| 自由现金流率自由现金流/营收 | 34.4% | 10.9% |
| 资本支出强度资本支出/营收 | 16.8% | 4.7% |
| 现金转化率经营现金流/净利润 | — | 0.42× |
| 过去12个月自由现金流最近4个季度 | $6.7B | $3.2B |
8季度趋势,按日历期对齐
经营现金流
AMT
VRTX
| Q1 26 | — | — | ||
| Q4 25 | $5.5B | $498.0M | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.3B | $818.9M | ||
| Q4 24 | $5.3B | $584.6M | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.3B | $-3.8B |
自由现金流
AMT
VRTX
| Q1 26 | $941.0M | — | ||
| Q4 25 | $3.8B | $348.6M | ||
| Q3 25 | $994.5M | $1.1B | ||
| Q2 25 | $976.9M | $927.4M | ||
| Q1 25 | $963.9M | $778.2M | ||
| Q4 24 | $3.7B | $492.0M | ||
| Q3 24 | $1.0B | $1.3B | ||
| Q2 24 | $1.0B | $-3.8B |
自由现金流率
AMT
VRTX
| Q1 26 | 34.4% | — | ||
| Q4 25 | 138.2% | 10.9% | ||
| Q3 25 | 36.6% | 37.0% | ||
| Q2 25 | 37.2% | 31.3% | ||
| Q1 25 | 37.6% | 28.1% | ||
| Q4 24 | 145.3% | 16.9% | ||
| Q3 24 | 41.4% | 47.0% | ||
| Q2 24 | 39.8% | -144.5% |
资本支出强度
AMT
VRTX
| Q1 26 | 16.8% | — | ||
| Q4 25 | 61.4% | 4.7% | ||
| Q3 25 | 17.1% | 3.3% | ||
| Q2 25 | 11.6% | 4.9% | ||
| Q1 25 | 12.9% | 1.5% | ||
| Q4 24 | 62.4% | 3.2% | ||
| Q3 24 | 16.8% | 2.4% | ||
| Q2 24 | 12.8% | 2.6% |
现金转化率
AMT
VRTX
| Q1 26 | — | — | ||
| Q4 25 | 6.53× | 0.42× | ||
| Q3 25 | 1.60× | 1.15× | ||
| Q2 25 | 3.37× | 1.04× | ||
| Q1 25 | 2.60× | 1.27× | ||
| Q4 24 | 4.30× | 0.64× | ||
| Q3 24 | — | 1.31× | ||
| Q2 24 | 1.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMT
暂无分部数据
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |